(FM) Oncología
Departamento académico
Leiden University Medical Center
Leiden, HolandaPublicaciones en colaboración con investigadores/as de Leiden University Medical Center (12)
2021
-
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
Virchows Archiv, Vol. 478, Núm. 2, pp. 153-190
-
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Radiotherapy and Oncology, Vol. 154, pp. 327-353
-
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
International Journal of Gynecological Cancer, Vol. 31, Núm. 1, pp. 12-39
-
Prevalence of nodal involvement in rectal cancer after chemoradiotherapy
The British journal of surgery, Vol. 108, Núm. 10, pp. 1251-1258
2020
2019
-
Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer
International Journal of Gynecological Cancer, Vol. 29, Núm. 7, pp. 1141-1147
-
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
The Lancet Oncology, Vol. 20, Núm. 6, pp. 862-876
2016
-
Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients
European Journal of Cancer, Vol. 69, pp. 127-134
-
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up
International Journal of Gynecological Cancer
-
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up
Annals of Oncology, Vol. 27, Núm. 1, pp. 16-41
2015
-
ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up
Radiotherapy and Oncology, Vol. 117, Núm. 3, pp. 559-581
2010
-
Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: Adjuvant chemotherapy prevents local recurrence rather than distant metastases
Annals of Oncology, Vol. 21, Núm. 6, pp. 1279-1284